Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from 43215
Breclav,
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from 43215
Breclav,
Click here to add this to my saved trials
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
699
mi
from 43215
Mobile, AL
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
96
mi
from 43215
Cincinnati, OH
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
96
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1982
mi
from 43215
Bakersfield, CA
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1982
mi
from 43215
Bakersfield, CA
Click here to add this to my saved trials
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
991
mi
from 43215
Doral, FL
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
991
mi
from 43215
Doral, FL
Click here to add this to my saved trials
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from 43215
Sebring, FL
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from 43215
Sebring, FL
Click here to add this to my saved trials
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
278
mi
from 43215
Evansville, IN
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
278
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
397
mi
from 43215
Saint Louis, MO
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
384
mi
from 43215
Clinton, SC
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A Phase IV, 12-week, Randomised, Double-blind, Triple Dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) With Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
384
mi
from 43215
Clinton, SC
Click here to add this to my saved trials
Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting
Evaluation of a Bronchoalveolar Lavage Procedure With a Flexible Disposable Bronchoscope, Ambu aScope 3 Large in Patients in an Intensive Care Unit Setting
Status: Enrolling
Updated:  12/31/1969
University of Chicago Medicine
274
mi
from 43215
Chicago, IL
Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting
Evaluation of a Bronchoalveolar Lavage Procedure With a Flexible Disposable Bronchoscope, Ambu aScope 3 Large in Patients in an Intensive Care Unit Setting
Status: Enrolling
Updated: 12/31/1969
University of Chicago Medicine
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study
Ventilation and Pulmonary Endothelium Toxicities (VaPE-Tox) of E-cigarettes: A Randomized Crossover Pilot Study
Status: Enrolling
Updated:  12/31/1969
Columbia University Irving Medical Center
442
mi
from 43215
New York, NY
Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study
Ventilation and Pulmonary Endothelium Toxicities (VaPE-Tox) of E-cigarettes: A Randomized Crossover Pilot Study
Status: Enrolling
Updated: 12/31/1969
Columbia University Irving Medical Center
442
mi
from 43215
New York, NY
Click here to add this to my saved trials
Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation Patients
Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation
Status: Enrolling
Updated:  12/31/1969
Nonin Medical, Inc.
633
mi
from 43215
Plymouth, MN
Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation Patients
Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation
Status: Enrolling
Updated: 12/31/1969
Nonin Medical, Inc.
633
mi
from 43215
Plymouth, MN
Click here to add this to my saved trials
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
406
mi
from 43215
Saint Louis, MO
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
406
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
360
mi
from 43215
Charlotte, NC
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
360
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
372
mi
from 43215
Raleigh, NC
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
372
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
4042
mi
from 43215
Antwerpen,
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
4042
mi
from 43215
Antwerpen,
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
515
mi
from 43215
Albany, NY
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
515
mi
from 43215
Albany, NY
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Northwell Health, Long Island Jewish Medical Center
493
mi
from 43215
New Hyde Park, NY
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Northwell Health, Long Island Jewish Medical Center
493
mi
from 43215
New Hyde Park, NY
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
SUNY Upstate Medical University
414
mi
from 43215
Syracuse, NY
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
SUNY Upstate Medical University
414
mi
from 43215
Syracuse, NY
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
St. Luke's CF Center of Idaho
1711
mi
from 43215
Boise, ID
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
St. Luke's CF Center of Idaho
1711
mi
from 43215
Boise, ID
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Indiana Clinical Research Center, IU Health University Hospital
167
mi
from 43215
Indianapolis, IN
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Indiana Clinical Research Center, IU Health University Hospital
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
643
mi
from 43215
Boston, MA
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine and St. Louis Children's Hospital
397
mi
from 43215
Saint Louis, MO
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine and St. Louis Children's Hospital
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Rutgers Robert Wood Johnson Medical School
455
mi
from 43215
New Brunswick, NJ
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Rutgers Robert Wood Johnson Medical School
455
mi
from 43215
New Brunswick, NJ
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh of UPMC
165
mi
from 43215
Pittsburgh, PA
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
995
mi
from 43215
Houston, TX
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
2005
mi
from 43215
Seattle, WA
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
The Cystic Fibrosis Center of Chicago
289
mi
from 43215
Glenview, IL
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
The Cystic Fibrosis Center of Chicago
289
mi
from 43215
Glenview, IL
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Spectrum Health Medical Group Adult Cystic Fibrosis Care Center
mi
from 43215
Grand Rapids, MI
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Spectrum Health Medical Group Adult Cystic Fibrosis Care Center
mi
from 43215
Grand Rapids, MI
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital
97
mi
from 43215
Cincinnati, OH
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Santiago Reyes, M.D.
850
mi
from 43215
Oklahoma City, OK
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Santiago Reyes, M.D.
850
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Sanford Children's Specialty Clinic
747
mi
from 43215
Sioux Falls, SD
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Sanford Children's Specialty Clinic
747
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
University of Tennessee Medical Center-Adult Cystic Fibrosis Clinic
282
mi
from 43215
Knoxville, TN
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
University of Tennessee Medical Center-Adult Cystic Fibrosis Clinic
282
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
University of Utah / Primary Childrens Medical Center
1511
mi
from 43215
Salt Lake City, UT
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
University of Utah / Primary Childrens Medical Center
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Yale New-Haven Medical Center
537
mi
from 43215
New Haven, CT
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Yale New-Haven Medical Center
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Advocate Children's Hospital - Park Ridge / North Suburban Pulmonary and Critical Care Consultants
289
mi
from 43215
Niles, IL
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Advocate Children's Hospital - Park Ridge / North Suburban Pulmonary and Critical Care Consultants
289
mi
from 43215
Niles, IL
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
154
mi
from 43215
Lexington, KY
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
345
mi
from 43215
Baltimore, MD
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
UMASS Memorial Medical Center
605
mi
from 43215
Worcester, MA
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
UMASS Memorial Medical Center
605
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Manchester
mi
from 43215
Manchester, NH
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Manchester
mi
from 43215
Manchester, NH
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
CF Therapeutics Development Center of Western New York
mi
from 43215
Buffalo, NY
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
CF Therapeutics Development Center of Western New York
mi
from 43215
Buffalo, NY
Click here to add this to my saved trials
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated:  12/31/1969
Clinical Research of Charlotte
348
mi
from 43215
Charlotte, NC
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Status: Enrolling
Updated: 12/31/1969
Clinical Research of Charlotte
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials